List of Tables
Table 1. Non Alcoholic Steatohepatitis Treatment Market Trends
Table 2. Non Alcoholic Steatohepatitis Treatment Market Drivers & Opportunity
Table 3. Non Alcoholic Steatohepatitis Treatment Market Challenges
Table 4. Non Alcoholic Steatohepatitis Treatment Market Restraints
Table 5. Global Non Alcoholic Steatohepatitis Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Non Alcoholic Steatohepatitis Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Non Alcoholic Steatohepatitis Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Non Alcoholic Steatohepatitis Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Non Alcoholic Steatohepatitis Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Non Alcoholic Steatohepatitis Treatment
Table 13. Global Non Alcoholic Steatohepatitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Alcoholic Steatohepatitis Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Non Alcoholic Steatohepatitis Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Non Alcoholic Steatohepatitis Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Non Alcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Non Alcoholic Steatohepatitis Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Non Alcoholic Steatohepatitis Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Non Alcoholic Steatohepatitis Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Non Alcoholic Steatohepatitis Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Non Alcoholic Steatohepatitis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Non Alcoholic Steatohepatitis Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Non Alcoholic Steatohepatitis Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Non Alcoholic Steatohepatitis Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. AstraZeneca Plc. Company Information
Table 58. AstraZeneca Plc. Introduction and Business Overview
Table 59. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 61. AstraZeneca Plc. Recent Development
Table 62. Tobira Therapeutics Inc. Company Information
Table 63. Tobira Therapeutics Inc. Introduction and Business Overview
Table 64. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 66. Tobira Therapeutics Inc. Recent Development
Table 67. Galmed Pharmaceuticals Company Information
Table 68. Galmed Pharmaceuticals Introduction and Business Overview
Table 69. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 71. Galmed Pharmaceuticals Recent Development
Table 72. Genfit SA Company Information
Table 73. Genfit SA Introduction and Business Overview
Table 74. Genfit SA Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Genfit SA Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 76. Genfit SA Recent Development
Table 77. Zydus Cadila Company Information
Table 78. Zydus Cadila Introduction and Business Overview
Table 79. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 81. Zydus Cadila Recent Development
Table 82. Bristol Myers Squibb Company Information
Table 83. Bristol Myers Squibb Introduction and Business Overview
Table 84. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 86. Bristol Myers Squibb Recent Development
Table 87. Gilead Science Company Information
Table 88. Gilead Science Introduction and Business Overview
Table 89. Gilead Science Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Gilead Science Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 91. Gilead Science Recent Development
Table 92. Conatus Pharmaceuticals Inc. Company Information
Table 93. Conatus Pharmaceuticals Inc. Introduction and Business Overview
Table 94. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 96. Conatus Pharmaceuticals Inc. Recent Development
Table 97. Novo Nordisk A/S Company Information
Table 98. Novo Nordisk A/S Introduction and Business Overview
Table 99. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 101. Novo Nordisk A/S Recent Development
Table 102. Immuron Ltd. Company Information
Table 103. Immuron Ltd. Introduction and Business Overview
Table 104. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 106. Immuron Ltd. Recent Development
Table 107. Raptor Pharmaceutical Corporation Company Information
Table 108. Raptor Pharmaceutical Corporation Introduction and Business Overview
Table 109. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 111. Raptor Pharmaceutical Corporation Recent Development
Table 112. Inventiva Pharma Company Information
Table 113. Inventiva Pharma Introduction and Business Overview
Table 114. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 116. Inventiva Pharma Recent Development
Table 117. NGM Biopharmaceuticals Inc. Company Information
Table 118. NGM Biopharmaceuticals Inc. Introduction and Business Overview
Table 119. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 121. NGM Biopharmaceuticals Inc. Recent Development
Table 122. Galectin Therapeutics Inc. Company Information
Table 123. Galectin Therapeutics Inc. Introduction and Business Overview
Table 124. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 126. Galectin Therapeutics Inc. Recent Development
Table 127. Madrigal Pharmaceuticals Company Information
Table 128. Madrigal Pharmaceuticals Introduction and Business Overview
Table 129. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 131. Madrigal Pharmaceuticals Recent Development
Table 132. Gemphire Therapeutics Company Information
Table 133. Gemphire Therapeutics Introduction and Business Overview
Table 134. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 136. Gemphire Therapeutics Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Non Alcoholic Steatohepatitis Treatment Downstream Customers
Table 140. Non Alcoholic Steatohepatitis Treatment Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Non Alcoholic Steatohepatitis Treatment Product Picture
Figure 2. Global Non Alcoholic Steatohepatitis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non Alcoholic Steatohepatitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Non Alcoholic Steatohepatitis Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Non Alcoholic Steatohepatitis Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Non Alcoholic Steatohepatitis Treatment Report Years Considered
Figure 7. Global Non Alcoholic Steatohepatitis Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Non Alcoholic Steatohepatitis Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non Alcoholic Steatohepatitis Treatment Revenue in 2023
Figure 10. Non Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Vitamin E And Pioglitazone Picture
Figure 12. Ocaliva Picture
Figure 13. Elafibranor Picture
Figure 14. Obeticholic Acid Picture
Figure 15. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Non Alcoholic Steatohepatitis Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Non Alcoholic Steatohepatitis Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Non Alcoholic Steatohepatitis Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Hospital Pharmacies
Figure 21. Product Picture of Retail And Specialty Pharmacies
Figure 22. Global Non Alcoholic Steatohepatitis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Non Alcoholic Steatohepatitis Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Non Alcoholic Steatohepatitis Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Non Alcoholic Steatohepatitis Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Non Alcoholic Steatohepatitis Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Non Alcoholic Steatohepatitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Non Alcoholic Steatohepatitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Non Alcoholic Steatohepatitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Non Alcoholic Steatohepatitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Non Alcoholic Steatohepatitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Non Alcoholic Steatohepatitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Non Alcoholic Steatohepatitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Non Alcoholic Steatohepatitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Non Alcoholic Steatohepatitis Treatment Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Non Alcoholic Steatohepatitis Treatment Sales Volume (%), (2019-2030)
Figure 39. United States Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Non Alcoholic Steatohepatitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Non Alcoholic Steatohepatitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Non Alcoholic Steatohepatitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Non Alcoholic Steatohepatitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. China Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Non Alcoholic Steatohepatitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. China Non Alcoholic Steatohepatitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Non Alcoholic Steatohepatitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Non Alcoholic Steatohepatitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Non Alcoholic Steatohepatitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Non Alcoholic Steatohepatitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Non Alcoholic Steatohepatitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Non Alcoholic Steatohepatitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 57. India Non Alcoholic Steatohepatitis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Non Alcoholic Steatohepatitis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 59. India Non Alcoholic Steatohepatitis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 60. Non Alcoholic Steatohepatitis Treatment Industrial Chain
Figure 61. Non Alcoholic Steatohepatitis Treatment Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
